AngioDynamics (ANGO) Q1 2025 Earnings Transcript

Motley Fool Transcribing, The Motley Fool

Tue, January 6, 2026 astatine 11:41 AM CST 34 min read

Image source: The Motley Fool.

Oct. 3, 2024 astatine 8:00 a.m. ET

• President and Chief Executive Officer — Jim Clemmer

• Executive Vice President and Chief Financial Officer — Steve Trowbridge

Operator: Good greeting and invited to the AngioDynamics Fiscal Year 2025 First Quarter Earnings Call. At this clip each participants are successful listen-only mode. A question-and-answer league volition travel the ceremonial presentation. [Operator Instructions] As a reminder, this league telephone is being recorded. The quality merchandise detailing AngioDynamics’ fiscal 2025 archetypal 4th results crossed the ligament earlier this greeting and is disposable connected the company's website. This league telephone is besides being broadcast unrecorded implicit the Internet astatine the Investors conception of the company's website astatine www.angiodynamics.com and a webcast replay of the telephone volition beryllium disposable astatine the aforesaid tract astir 1 hr aft the extremity of today's call.

Before we begin, I would similar to caution listeners that during the people of this league call, the institution volition marque projections oregon forward-looking statements regarding aboriginal events, including statements astir expected revenue, adjusted earnings, and gross margins for fiscal twelvemonth 2025, arsenic good arsenic trends that whitethorn continue. Management encourages you to reappraisal the company's past and aboriginal filings with the SEC, including without regulation the company’s Form 10-Q and 10-K, which place circumstantial factors that whitethorn origin the existent results oregon events to disagree materially from those described successful the forward-looking statements. Company volition besides sermon definite non-GAAP and pro forma fiscal measures during this call.

Management uses these measures to found operational goals and reappraisal operational show and believes that these measures whitethorn assistance investors successful analyzing the underlying trends successful the company's concern implicit time. Investors should see these non-GAAP and pro forma measures successful summation to, not arsenic a substitute for, oregon arsenic superior to fiscal reporting measures prepared successful accordance with GAPP. The descent bundle offering penetration into the company's fiscal results is besides disposable connected the Investors conception of the company's website nether Events and Presentations. This presumption should beryllium work successful conjunction with the property merchandise discussing the company's operating results and fiscal show during this morning's league call.

I'd present similar to crook the telephone implicit to Jim Clemmer, AngioDynamics’ President and Chief Executive Officer. Mr. Clemmer.